» Authors » Stefania Zanussi

Stefania Zanussi

Explore the profile of Stefania Zanussi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 277
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazziotta C, Badiale G, Cervellera C, Tonnini G, Oimo M, Touze A, et al.
Microb Biotechnol . 2024 Oct; 17(10):e14536. PMID: 39460382
Merkel cell polyomavirus (MCPyV) is the foremost causative factor of Merkel cell carcinoma (MCC), a rare yet highly aggressive skin cancer. Although the evaluation of circulating IgG antibodies against Merkel...
2.
Brisotto G, Montico M, Turetta M, Zanussi S, Cozzi M, Vettori R, et al.
Viruses . 2023 Jun; 15(6). PMID: 37376576
Cellular and humoral immunity are both required for SARS-CoV-2 infection recovery and vaccine efficacy. The factors affecting mRNA vaccination-induced immune responses, in healthy and fragile subjects, are still under investigation....
3.
Caccuri F, Messali S, Zani A, Campisi G, Giovanetti M, Zanussi S, et al.
Proc Natl Acad Sci U S A . 2022 Jun; 119(27):e2122050119. PMID: 35763571
AIDS-defining cancers declined after combined antiretroviral therapy (cART) introduction, but lymphomas are still elevated in HIV type 1 (HIV-1)-infected patients. In particular, non-Hodgkin's lymphomas (NHLs) represent the majority of all...
4.
Brisotto G, Muraro E, Montico M, Corso C, Evangelista C, Casarotto M, et al.
Clin Chim Acta . 2021 Nov; 523:476-482. PMID: 34755649
Background And Aims: Monitoring the immune response against SARS-CoV-2 is pivotal in the evaluation of long-term vaccine efficacy. Immunoglobulin G (IgG) antibodies represent an advisable tool to reach this goal,...
5.
Cangemi M, Zanussi S, Rampazzo E, Bidoli E, Giunco S, Tedeschi R, et al.
Front Oncol . 2021 Nov; 11:772348. PMID: 34746013
Background: tumors are a major cause of morbidity and mortality after long-term solid organ transplantation. Chronic immunosuppression strongly affects solid organ transplanted (SOT) patients' immune system by promoting immune evasion...
6.
De Re V, De Zorzi M, Caggiari L, Repetto O, Brisotto G, Magris R, et al.
Microorganisms . 2021 Jan; 9(1). PMID: 33430456
Background: Pepsinogen (PG) II (PGII) is a serological marker used to estimate the risk of gastric cancer but how PGII expression is regulated is largely unknown. It has been suggested...
7.
De Re V, Brisotto G, Repetto O, De Zorzi M, Caggiari L, Zanussi S, et al.
Int J Mol Sci . 2020 Dec; 21(24). PMID: 33321820
Gastric cancer (GC) is a deadly disease with poor prognosis that is characterized by heterogeneity. New classifications based on histologic features, genotypes, and molecular phenotypes, for example, the Cancer Genome...
8.
De Re V, Tornesello M, De Zorzi M, Caggiari L, Pezzuto F, Leone P, et al.
Liver Int . 2020 Sep; 41(1):133-149. PMID: 32937024
Background: Genetic variants of IFNL4 and PDCD1 genes have been shown to influence the spontaneous clearance of hepatitis C virus (HCV) infection. We investigated the IFNL4 rs12979860 and the PDCD1...
9.
Casarotto M, Pratesi C, Bidoli E, Maiero S, Magris R, Steffan A, et al.
Pathogens . 2019 May; 8(2). PMID: 31109082
() represents an independent risk factor for Gastric Cancer (GC). First Degree Relatives (FDR) of GC subjects and Autoimmune Gastritis (AG) patients are both at increased risk for GC. genetic...
10.
De Re V, Repetto O, De Zorzi M, Casarotto M, Tedeschi M, Giuffrida P, et al.
Cancers (Basel) . 2019 May; 11(5). PMID: 31083432
Autoimmune atrophic gastritis (AAG) is associated with an increased risk of certain types of gastric cancer (GC). () infection may have a role in the induction and/or maintenance of AAG...